Eishlon Pharmacon Private Limited
About Eishlon Pharmacon Private Limited
Data last updated:
Eishlon Pharmacon Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999HR2018PTC072646. Its GSTIN is 06AAECE9387M1ZX (Haryana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors including Ashok Kumar and Ankit Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 45 Vita Enclave, Ambala, Haryana, India – 134003.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.45 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹2.1 Lakh (net margin 0.9%) and EBITDA of ₹9.55 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 17% over five years.
Court records list 18 cases involving the company, including 18 filed by the company; 12 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Eishlon Pharmacon Private Limited's registered office is in Ambala, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 45 Vita Enclave, Ambala, Haryana, India – 134003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Eishlon Pharmacon Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Eishlon Pharmacon Private Limited
FY 2025 filings availableEishlon Pharmacon Private Limited reported revenue of ₹2.45 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 12% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eishlon Pharmacon Private Limited, buy the company report.
Board of directors of Eishlon Pharmacon Private Limited
Eishlon Pharmacon has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Kumar Also directs: Agrawal Life Care Private Limited | Director | 13 Aug 2018 | 8 Years 2 Months | Current |
| Ankit Agrawal Also directs: Agrawal Life Care Private Limited | Director | 20 Feb 2018 | 8 Years 8 Months | Current |
| Preeti Agrawal | Director | 17 Sep 2018 | 8 Years 1 Months | Current |
Auditor
Eishlon Pharmacon Private Limited is audited by AJAY N & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY N & ASSOCIATES | FY 2023 | 511570 |
Shareholding
The shareholding of Eishlon Pharmacon Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eishlon Pharmacon Private Limited, buy the company report.
Legal cases
Eishlon Pharmacon Private Limited has 18 court cases on record: 18 filed by Eishlon Pharmacon. 12 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 18 | 0 | 12 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Muzaffarpur, Bihar | Court case (CRI. REVISION) | Filed by the company against State of Bihar | Pending |
| District court, Muzaffarpur, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against Binda Prasad Gupta, M/S Dhan Kuber Medical Agency | Pending |
| District court, Muzaffarpur, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against Birendra Prasad Baranwal (Proprietor R.B Pharma) | Pending |
| District court, Muzaffarpur, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Pending |
| District court, Muzaffarpur, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against Bibha Devi (Prop. of M/S. Chanda Pharma) | Pending |
To see the full case history of Eishlon Pharmacon Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eishlon Pharmacon Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eishlon Pharmacon has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECE9387M1ZX | Haryana | Active | 23 Jun 2022 |
| 10AAECE9387M1Z8 | Bihar | Active | 10 Apr 2018 |
To see the full GST registrations and return filing status of Eishlon Pharmacon Private Limited, buy the company report.
Recent activity
Eishlon Pharmacon Private Limited has 6 board changes on record since 2018: 3 appointments and 3 cessations. The latest: Ronit Kumar ceased to be Director on 07 Jul 2025.
Frequently asked questions
Eishlon Pharmacon is an active private limited company based in Ambala, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 February 2018 (8+ years old) and is registered under CIN U74999HR2018PTC072646.
Eishlon Pharmacon has 3 current directors:
- Ashok Kumar - Director
- Ankit Agrawal - Director
- Preeti Agrawal - Director
The latest financial statements of Eishlon Pharmacon on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Eishlon Pharmacon is 06AAECE9387M1ZX, registered in Haryana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AAECE9387M1Z8 (Bihar).
The CIN (Corporate Identification Number) of Eishlon Pharmacon is U74999HR2018PTC072646. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eishlon Pharmacon has 18 court cases on record: 18 filed by the company. 12 are pending.
Eishlon Pharmacon was incorporated on 20 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Ronit Kumar ceased to be Director on 07 Jul 2025. Usha Agrawal ceased to be Director on 07 Jul 2025. Preeti Agrawal was appointed as Director on 17 Sep 2018. Eishlon Pharmacon has 6 board changes on record in total.
The registered office of Eishlon Pharmacon is at Shop No. 45 Vita Enclave, Ambala, Haryana, India – 134003.
Eishlon Pharmacon operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
